Pfizer Patent on Known Substance: A Section 3(d) Analysis
This post examines Pfizer’s patent application on a known substance and the Indian Patent Office’s refusal in light of Section 3d and the Novartis decision. It discusses whether…
Indian Patent Office
193 articles
New Computer Related Inventions Guidelines
The Indian Patent Office has replaced earlier provisions with new Guidelines for Computer Related Inventions, clarifying patentability criteria under section 3k of the Patents Act. The Guidelines provide…
Intellectual Property (IP) in India: A Decade of Progress Part 4
This post examines a decade of patent filing statistics across Indian states, highlighting Maharashtra’s leading position. It offers a structured analysis of regional trends in intellectual property creation,…
Intellectual Property (IP) in India: A Decade of Progress Part 2
This post analyses a decade of patent statistics, examining trends in filings, grants, examinations, and revenue in India. It reflects on the evolving landscape of intellectual property rights,…
IISc and its Patent Prowess
The Indian Institute of Science, renowned for research excellence, has filed fewer than fifty patents annually in recent years, with limited commercialization. This analysis examines IISc’s patent trends…
Filing a PCT Application in India? Get your FFL ready!
Filing a PCT application in India demands strict adherence to Section 39 of the Patents Act, including obtaining a Foreign Filing License. This post explains the procedural requirements…
Congratulations to Rajiv Aggarwal, India’s New Controller General of Patents, Designs and Trade Marks
Rajiv Aggarwal has taken charge as the new Controller General of Patents, Designs and Trade Marks, signaling ongoing reform in India’s IP administration. His tenure is expected to…
InPASS: New Patent Full-Text Search Tool from IPO
InPASS, the Indian Patent Advanced Search System, was launched by the Indian Patent Office in February 2015 to provide full-text patent search functionality. This initiative aims to increase…
‘Killead’s Patent Application Killed by the Indian Patent Office!
Gilead’s patent for Sofosbuvir was rejected by the Indian Patent Office on grounds of insufficient therapeutic efficacy. This landmark decision enables wider access to affordable generic Hepatitis C…
Roche’s backbone rendered brittle by Indian Patent Office
The Indian Patent Office has revoked Roche’s patent on Bonviva after Cipla challenged its validity, citing a lack of inventive step and patentability. This decision highlights critical aspects…